Managing Anxiety and Depression in Parkinson’s Disease

A combination of medication and other therapies can help ease non-motor symptoms affecting those with Parkinson’s disease.

1:00 PM

Author | Andrew J. Ridder, M.D.

Silhouette showing anxiety & depression in Parkinson’s disease

Most people think of Parkinson's disease as marked only by tremors, muscular rigidity and slow, imprecise movements, but Parkinson's is more than a movement disorder.

Most people with Parkinson's also have quite a few non-motor symptoms, such as anxiety, depression and psychosis. Many of these symptoms may have started before the Parkinson's disease became obvious.

The effects are widespread. Several years ago, a large clinical study of more than 1,000 people with Parkinson's disease of various durations demonstrated that only 1.4 percent of the participants did not report any non-motor symptoms.

In other words, 98.6 percent of the study participants had some form of NMS. Psychiatric symptoms accounted for 60 percent, while visual hallucinations that could have signified psychosis were present in about 35 percent of patients.

That's why taking action is important. If you or a loved one has had a new diagnosis of Parkinson's disease, we recommend an immediate evaluation for depression, mood and cognitive problems. Frequent monitoring should also be done throughout the course of the disease.

Here are some of the common symptoms and treatment methods for Parkinson's patients with depression and dementia:

Identifying and treating depression

Between 17 to 50 percent of patients with Parkinson's have depression. Depression and Parkinson's have so many similar-looking symptoms that it is hard to tell the difference between them.

It's important to note, however, that depression is not a reaction to the disability. Rather, it seems to be related to the degeneration of specific neurons in Parkinson's disease itself.

Typical symptoms include:

  • Sadness

  • Pessimism

  • Decreased interest in activities

  • Slowing of movements

  • Fatigue

  • Mild to moderate depression

Major depression is accompanied with guilt and self-blame, which you don't often see in Parkinson's disease depression.

To treat depression in these cases, we would use the same treatments used to treat depression in the general population.

  • Selective serotonin reuptake inhibitors (SSRIs) such as paroxetine or sertraline

  • Serotonin/norepinephrine reuptake inhibitors (SNRIs) such as venlafaxine

  • Tricyclic antidepressants or MAO-B inhibitors are rarely used

  • Cognitive behavioral therapy: A type of psychotherapy in which the patient is given the tools to change negative patterns of thought about how they're reacting to things, coping with family members and their abilities. It is often combined with medications.

  • Vagus nerve stimulation, also known as vagal nerve stimulation: A medical treatment that involves delivering electrical impulses to the vagus nerve. It is used as an additional therapy for treatment-resistant depression and certain types of uncontrollable epilepsy. If you have deep brain stimulation leads in, this is not an option.

  • Electroconvulsive therapy, also known as electroshock therapy: A procedure done under general anesthesia in which small electric currents are passed through the brain to intentionally trigger a brief seizure. This seems to cause changes in brain chemistry that can quickly reverse symptoms of certain mental illness. It is highly effective and well tolerated in refractory depression.

Anxiety: Symptoms and treatment

About 5 to 40 percent of people with Parkinson's disease also have a clinical diagnosis of anxiety — feelings of worry, nervousness or unease that may be accompanied by compulsive behavior or panic attacks. Some of these symptoms can be worse or occur only when Sinemet is wearing off ("off times").

To treat anxiety in Parkinson's patients, we would use one or a combination of the following:

  • Cognitive behavioral therapy

  • Psychotherapy

  • Relaxation techniques

  • Adjust the carbidopa-levodopa (Sinemet) regiment to treat any anxiety that occurs during medication "off" times

  • Medications used for depression as described above usually work well for anxiety

  • Anxiolytics like lorazepam (Ativan) or diazepam (Valium) are rarely used due to effects on thinking and alertness

A need for caution

Doctors have to be careful which medications they prescribe. Some antipsychotic medications, for example, risk making Parkinson's motor symptoms worse — or, in combination with Parkinson's medications, can worsen any psychosis.

Cognitive & Psychiatric Disorders in Parkinson's Disease - Andrew Ridder, MD

Watch Dr. Ridder's talk from the University of Michigan's 2016 Parkinson's & You Symposium. Dr. Ridder explains the non-motor (non-movement) cognitive and psychiatric problems seen in people with Parkinson's disease, focusing on frequency, symptoms and treatment options.


More Articles About:

Health Management Parkinson's Disease anxiety Depression Neurological (Brain) Conditions
Health Lab word mark overlaying blue cells

Health Lab

Explore thousands of health news & research stories by visiting the Health Lab homepage for more.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

female surgeon on ground upset hands to face in scrubs and scrub shoes
Health Lab

Depression in OBGYN residents needs more attention, study suggests

New onset depression in obstetrics and gynecology residents in their intern year is common and often untreated, and linked to depression history, higher work hours and less sleep.
Cole, wearing sunglasses and a purple Calming the Storm t-shirt with a rainbow, is seated on a blanket outdoors and holding a Mott teddy bear.
Philanthropy News

A pediatric epilepsy fundraiser that changes lives

Your support of Calming the Storm advances pediatric epilepsy research and patient care programs. There are many ways you can contribute to make a difference for so many children and families.
graphic of red green orange blue close up of inside of body and insides shaking
Health Lab

Pain, psychological factors and physical function closely linked in people with systemic sclerosis

For many people living with chronic conditions like systemic sclerosis, pain can be persistent, unpredictable, and difficult to manage leading to a strong impact on a patient’s mental health.
Doctor performing a test
News Release

Michigan Alzheimer's Disease Research Center receives $22M to advance efforts statewide

NIH renews $22M for Michigan Alzheimer's Disease Research Center, supporting a first-of-its-kind statewide partnership and dementia research.
cells close up blue and green background microscope
Health Lab

Engineered nanoparticles sensitize gliomas to radiotherapy

University of Michigan researchers discovered a new pathway that sensitizes mIDH1 gliomas to radiation in human and mouse mIDH1 glioma cells and mouse models, paving the way for phase 1 clinical trials in humans
Health Lab Podcast in brackets with a background with a dark blue translucent layers over cells
Health Lab Podcast

Studying Period Pain

A study looks at risk factors for pain with menstruation in adolescents.